Strategic Positioning InnovaGel operates under KD Nutra, a KD Pharma Group company, signaling strong backing and integration into a larger pharmaceutical manufacturing ecosystem that can unlock collaboration on larger scale projects and access to broader distribution channels.

Mid-size Advantage With 11-50 employees and revenue in the 10–25 million range, InnovaGel is positioned as a nimble player capable of rapid decision making while still delivering with the scale and reliability expected from a KD Pharma-backed entity, making it an attractive partner for contract manufacturing and ingredient supply.

Productive Synergies As a collagen or gelatin-focused manufacturer (aligned with KD Nutra’s portfolio), there are clear cross-sell opportunities to expand into KD Pharma’s existing customer base seeking high-quality collagen-based ingredients and finished solutions.

Growth Signals Revenue visibility at the mid-market level suggests room for expansion through co-development, private-label projects, and larger production runs, supported by KD Pharma’s resources to scale manufacturing capabilities and regulatory support.

Competitive Positioning Positioned among larger peers in the collagen ingredient space, InnovaGel can differentiate through agility, customization, and direct access to KD Pharma’s global network, enabling targeted pitches to manufacturers and brands seeking reliable supply with scalable capacity.